ARTICLE | Translation in Brief

ArunA’s exosome entrance

Why ArunA decided to develop exosome therapeutics for stroke

January 4, 2018 7:27 PM UTC

Stem cell manufacturer ArunA Biomedical Inc. has announced a pivot into the exosome therapeutic space, as well as publication of the first data showing its neural stem cell-derived exosomes and other extracellular vesicles are effective in mouse models of stroke.

ArunA launched in 2003 to provide stem cells to the research community...